Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biopsy
Johns Hopkins University publishes research in biopsy
July 1st, 2008
According to recent research from the United States, "We examined contralateral prostate cancer potentially left behind by focal therapy. We investigated 100 completely embedded radical prostatectomy specimens in which needle biopsy predicted limited disease (less than 3 positive cores, 50% or less involvement of any positive core, Gleason score 6 or less) and all positive needle cores were unilateral." "Clinical stage was T1c in 85 and T2a in 15 cases with the palpable lesion on the positive biopsy side. There was 1 positive core in 66 cases. On average 13.9% of each positive core was involved with tumor. The mean number of separate tumor nodules per radical...
Source: Cancer Weekly (2008-07-01)
|
